BACKGROUND: Catheter ablation using radiofrequency (RF) energy is an established treatment for ventricular tachycardia (VT). Tissue temperature is a key determinant of successful lesion creation, and yet, it is difficult to measure during conventional RF ablation because of the cooling effect of high-flow rate saline irrigation. The TRAC-VT study evaluated the safety and efficacy of a novel irrigated RF ablation system modulating power based on real-time tissue temperature. METHODS: Patients with sustained monomorphic VT and structural heart disease (SHD) were enrolled. Catheter ablation was performed in temperature-control mode (irrigation 8 ml/min, temperature set-points 55 or 60 °C, and power output ≤ 50 W), with RF applications for ≤ 45 s. The primary safety endpoint was a composite of cardiovascular-specific serious procedure-related adverse events within 30 days post-ablation. The primary effectiveness endpoint was acute success (i.e., non-inducibility of all clinically relevant VTs). RESULTS: Thirty-eight patients were enrolled with monomorphic VT (age 68 ± 12 years and 84% male), with an average of 1.7 ± 1.2 VTs targeted per patient. In total, 41 ± 23 RF applications per patient were delivered. Acute procedural success was 100% (95% CI, 91-100%). No primary safety endpoints were observed. Six-month follow-up was completed in 92% of patients with 81% (95% CI, 65-91%) freedom from sustained or treated VT. A repeat ablation was performed in three patients. CONCLUSIONS: Ablation of VT in SHD, using a temperature-controlled irrigated RF catheter, was safe and effective with a low rate of VT recurrence at 6 months.

Cardiologie CHU de Rouen Rouen France

Department of Biomedical Surgical and Dental Sciences University of Milan Milan Italy

Department of Cardiology Hospital Universitario Ramón y Cajal Madrid Spain

Department of Cardiology University Hospitals Coventry and Warwickshire NHS Trust Coventry UK

Dept of Clinic Electrophysiology and Cardiac Pacing Heart Rhythm Center Centro Cardiologico Monzino Milan Italy

Heart Rhythm Research Group Division of Biomedical Sciences Warwick Medical School Clinical Sciences Research Laboratory Coventry UK

Institute for Clinical and Experimental Medicine Prague Czechia

Medtronic Minneapolis USA

Zobrazit více v PubMed

Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, Reichlin T, … ESC Scientific Document Group. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997–4126. 10.1093/eurheartj/ehac2622. PubMed

Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N, Aguinaga L, Leite LR, Al-Khatib SM, Anter E, Berruezo A, Callans DJ, Chung MK, Cuculich P, d'Avila A, Deal BJ, Della Bella P, Deneke T, Dickfeld TM, Hadid C, … ESC Scientific Document Group. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Europace : Eur Pacing, Arrhythmias Card Electrophysiol : J Work Groups Card Pacing Arrhythmias Cardiac Cell Electrophysiol Eur Soc Cardiol. 2019;21(8):1143–1144. 10.1093/europace/euz132.

Breithardt G, Borggrefe M. The dawn of radiofrequency catheter ablation for cardiac arrhythmias. Heart Rhythm. 2021;18(3):485–6. 10.1016/j.hrthm.2020.11.0304. PubMed

Yokoyama K, Nakagawa H, Wittkampf FH, Pitha JV, Lazzara R, Jackman WM. Comparison of electrode cooling between internal and open irrigation in radiofrequency ablation lesion depth and incidence of thrombus and steam pop. Circulation. 2006;113(1):11–9. 10.1161/CIRCULATIONAHA.105.540062. PubMed

Stoffregen WC, Maddox W, Cuoco F, McElderry HT. Abstract B-PO02-094, Temperature sensing accuracy and lesion characteristics of a novel, diamond tip, temperature controlled open irrigated radiofrequency catheter. Heart Rhythm. 2018;15(5):S218.

Iwasawa J, Koruth JS, Petru J, Dujka L, Kralovec S, Mzourkova K, Dukkipati SR, Neuzil P, Reddy VY. Temperature-controlled radiofrequency ablation for pulmonary vein isolation in patients with atrial fibrillation. J Am Coll Cardiol. 2017;70(5):542–53. 10.1016/j.jacc.2017.06.008. PubMed

Dhanjal TS, Schmidt MM, Getman MK, Brigham RC, Al-Sheikhli J, Patchett I, Robinson MR. Characterizing lesion morphology of a novel diamond-tip temperature-controlled irrigated radiofrequency ablation catheter. J Interv Cardiac Electrophysiol : Int J Arrhythmias Pacing. 2024;67(2):293–301. 10.1007/s10840-023-01595-9. PubMed PMC

Al-Sheikhli J, Patchett I, Lim VG, Marshall L, Foster W, Kuehl M, Yusuf S, Panikker S, Patel K, Osman F, Banerjee P, Lellouche N, Dhanjal T. Initial experience of temperature-controlled irrigated radiofrequency ablation for ischaemic cardiomyopathy ventricular tachycardia ablation. J Interv Cardiac Electrophysiol : Int J Arrhythmias Pacing. 2023;66(3):551–9. 10.1007/s10840-022-01158-4. PubMed PMC

Ghanbari H, Baser K, Yokokawa M, Stevenson W, Della Bella P, Vergara P, Deneke T, Kuck KH, Kottkamp H, Fei S, Morady F, Bogun F. Noninducibility in postinfarction ventricular tachycardia as an end point for ventricular tachycardia ablation and its effects on outcomes: a meta-analysis. Circ Arrhythm Electrophysiol. 2014;7(4):677–83. 10.1161/CIRCEP.113.001404. PubMed

Santangeli P, Higuchi K, Sroubek J. Ventricular tachycardia ablation endpoints: moving beyond noninducibility. JACC. Clin Electrophysiol. 2024;S2405–500X(24)00003–3. Advance online publication. 10.1016/j.jacep.2023.12.009. PubMed

US FDA Premarket Approval Application (PMA) Number: P110016/S080. 2022. https://www.accessdata.fda.gov/cdrh_docs/pdf11/P110016S080B.pdf. Accessed 29 Mar 2024.

Tung R, Vaseghi M, Frankel DS, Vergara P, Di Biase L, Nagashima K, Yu R, Vangala S, Tseng CH, Choi EK, Khurshid S, Patel M, Mathuria N, Nakahara S, Tzou WS, Sauer WH, Vakil K, Tedrow U, Burkhardt JD, Tholakanahalli VN, … Shivkumar K. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group study. Heart Rhythm. 2015;12(9), 1997–2007. 10.1016/j.hrthm.2015.05.036. PubMed PMC

Maury P, Baratto F, Zeppenfeld K, Klein G, Delacretaz E, Sacher F, Pruvot E, Brigadeau F, Rollin A, Andronache M, Maccabelli G, Gawrysiak M, Brenner R, Forclaz A, Schlaepfer J, Lacroix D, Duparc A, Mondoly P, Bouisset F, Delay M, … De Chillou C. Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%. Eur Heart J. 2014;35(22):1479–1485. 10.1093/eurheartj/ehu040. PubMed

Calkins H, Epstein A, Packer D, Arria AM, Hummel J, Gilligan DM, Trusso J, Carlson M, Luceri R, Kopelman H, Wilber D, Wharton JM, Stevenson W. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. Cooled RF Multi Center Investigators Group. J Am Coll Cardiol. 2000;35(7):1905–14. 10.1016/s0735-1097(00)00615-x. PubMed

Seiler J, Roberts-Thomson KC, Raymond JM, Vest J, Delacretaz E, Stevenson WG. Steam pops during irrigated radiofrequency ablation: feasibility of impedance monitoring for prevention. Heart Rhythm. 2008;5(10):1411–6. 10.1016/j.hrthm.2008.07.011. PubMed

Viles-Gonzalez JF, Berjano E, d’Avila A. Complications of radiofrequency catheter ablation: can we prevent steam pops? JACC Clin Electrophysiol. 2018;4(4):501–3. 10.1016/j.jacep.2017.11.003. PubMed